Dr. Viviane Zotzmann | Intensive Care Medicine | Best Researcher Award

Ortenau Klinikum Offenburg-Kehl, Germany.

PD Dr. med. Viviane Zotzmann is a Senior Consultant for Intensive Care Medicine at Ortenau Klinikum, specializing in internal medicine and cardiology with additional expertise in emergency and intensive care medicine. She has trained in both municipal hospitals and the University Hospital of Freiburg. Dr. Zotzmann is currently responsible for two intensive care units in Offenburg and Lahr. Her research focuses on ECMO therapy, with particular interest in survival predictors, quality of life, and functional outcomes post-therapy. She is an active member of professional societies such as DGK, DEGUM, DIVI, and DGIM.

Profile

Orcid

🎓 Education

Dr. Viviane Zotzmann holds a Doctor of Medicine (Dr. med.) degree from the University of Tübingen (2005). She is a board-certified specialist in Internal Medicine (2013), Cardiology (2017), and Intensive Care Medicine (2018), with further certification in Cardiovascular Intensive and Emergency Medicine (2022). In addition, she is an Advanced Life Support & Pediatric Life Support Provider (2023). Dr. Zotzmann has also completed additional training in Sonography, Emergency Medicine, and Radiation Protection.

🏥 Professional Experience

Dr. Viviane Zotzmann is a highly experienced medical professional specializing in intensive care, cardiology, and emergency medicine. She currently serves as the Head of Intensive Care Medicine at Ortenau Klinikum (2025 – Present). Previously, she held the position of Senior Consultant at Ortenau Klinikum (2023 – 2025), overseeing Cardiology, Pneumology, Angiology, Geriatrics, Intensive Care, and Thoracic Surgery.

From 2020 to 2023, Dr. Zotzmann was the Lead Physician of Medical Intensive Care Units at University Hospital Freiburg, following her role as a Specialist Physician at the same institution (2016 – 2020). Before that, she served as Senior Physician in Internal Medicine/Cardiology at Zollernalbklinikum (2014 – 2015).

Her medical journey began with specialist training in Internal Medicine & Cardiology at KKH Sigmaringen (2010 – 2014), solidifying her expertise in critical and cardiovascular care.

🔬 Research Interests

Extracorporeal Membrane Oxygenation (ECMO) therapy

Predictors of survival in VV-ECMO and VA-ECMO patients

Quality of life and mental health in post-ECMO patients

Pulmonary embolism diagnosis in ICU patients

Advanced intensive care monitoring and life-support techniques

🏆 Awards & Recognitions

Recognized contributor to ECMO research

Published in high-impact journals such as Intensive Care Medicine and Membranes (Basel)

Cited over 1,044 times with an h-index of 18

📚 Selected Publications

Quality of Life and Mental Health in COVID-ARDS Survivors After V-V ECMO Support: Results from the Freiburg ECMO Outcome Study (FEOS)
Journal of Clinical Medicine, 2025-03-24
DOI: 10.3390/jcm14072206
Contributors: Dawid L. Staudacher, Meret Felder, Markus Jäckel, Felix A. Rottmann, Alexander Supady, Xavier Bemtgen, Philipp Diehl, Tobias Wengenmayer, Viviane Zotzmann

Combining Lung Ultrasound and Wells Score for Diagnosing Pulmonary Embolism in Critically Ill COVID-19 Patients
Journal of Thrombosis and Thrombolysis, 2021-07-03
DOI: 10.1007/s11239-020-02323-0
Contributors: Viviane Zotzmann, Corinna N. Lang, Tobias Wengenmayer, Xavier Bemtgen, Bonaventura Schmid, Katharina Mueller-Peltzer, Alexander Supady, Christoph Bode, Daniel Duerschmied, Dawid L. Staudacher

Combining Lung Ultrasound and Wells Score for Diagnosing Pulmonary Embolism in Critically Ill COVID-19 Patients (Preprint)
2020-09-08
DOI: 10.21203/rs.3.rs-70085/v1
Contributors: Viviane Zotzmann, Corinna Nadine Lang, Tobias Wengenmayer, Xavier Bemtgen, Bonaventura Schmid, Katharina Mueller-Peltzer, Alexander Supady, Christoph Bode, Daniel Duerschmied, Dawid L. Staudacher

Venoarterial Extracorporeal Membrane Oxygenation Decannulation Using the Novel Manta Vascular Closure Device
European Heart Journal: Acute Cardiovascular Care, 2020-05-04
DOI: 10.1177/2048872620918707
Author: V. Zotzmann

Are Subpleural Consolidations Indicators for Segmental Pulmonary Embolism in COVID-19?
Intensive Care Medicine, 2020-04-23
DOI: 10.1007/s00134-020-06044-z
Author: V. Zotzmann

Dr. Jie Liu | Medicinal Plants | Best Researcher Award

Dr. Jie Liu, a dedicated researcher at Taizhou University, Zhejiang Province, China, specializes in plant polyploid breeding with a significant focus on medicinal plant polyploids. Renowned for developing the innovative "primordial meristem method," she has made substantial contributions to understanding the cytological and molecular mechanisms of polyploids and their pharmacological enhancements. Her work bridges agricultural advancements and medicinal innovation, fostering solutions with global impact.

Education 🎓

Dr. Jie Liu holds a PhD in Plant Science, with her doctoral research focusing on plant polyploid breeding. This specialization highlights her expertise in enhancing the genetic traits and pharmacological properties of medicinal plants. Following her PhD, she pursued post-doctoral research, delving deeper into the molecular mechanisms and cytological features of polyploid plants. Her advanced studies refined her scientific rigor and fostered innovative approaches to understanding and applying polyploidy in agriculture and pharmacology.

Research Interests 🔬

Polyploid Breeding

Dr. Liu focuses on developing innovative methods to enhance plant productivity and improve the medicinal value of polyploid plants, pushing the boundaries of agricultural and pharmaceutical applications.

Cytological and Molecular Mechanisms

Her research investigates the genetic and molecular foundations of polyploid traits, providing critical insights into the biological processes driving these unique characteristics.

Pharmacological Applications

Dr. Liu explores how polyploidy influences the therapeutic properties of medicinal plants, aiming to optimize their pharmacological potential for broader medical and commercial use.

Publications 📚